Xortx Therapeutics Inc
(XRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,832 | -7,719 | -5,140 | -3,943 | -2,704 |
| Depreciation Amortization | 18 | 58 | 36 | 14 | 4 |
| Accounts receivable | 45 | -41 | -23 | -153 | -84 |
| Other Working Capital | -745 | 1,474 | 1,716 | 735 | 318 |
| Other Operating Activity | 29 | -2,736 | -1,939 | -1,035 | -37 |
| Operating Cash Flow | $-2,485 | $-8,964 | $-5,350 | $-4,382 | $-2,504 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -20 | -14 | -15 | N/A |
| Purchase Sale Intangibles | -17 | -26 | -15 | -10 | -3 |
| Other Investing Activity | -17 | -26 | -15 | -10 | -3 |
| Investing Cash Flow | $-20 | $-46 | $-29 | $-24 | $-3 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 5,000 | N/A | N/A | N/A |
| Other Financing Activity | -22 | -290 | -467 | -6 | 0 |
| Financing Cash Flow | $-22 | $4,710 | $-467 | $-6 | $N/A |
| Exchange Rate Effect | 1 | -136 | -152 | -43 | 48 |
| Beginning Cash Position | 10,434 | 14,870 | 14,870 | 14,870 | 14,870 |
| End Cash Position | 7,909 | 10,434 | 8,872 | 10,414 | 12,412 |
| Net Cash Flow | $-2,526 | $-4,436 | $-5,998 | $-4,455 | $-2,458 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,485 | -8,964 | -5,350 | -4,382 | -2,504 |
| Capital Expenditure | -3 | -20 | -14 | -15 | N/A |
| Free Cash Flow | -2,488 | -8,983 | -5,364 | -4,397 | -2,504 |